Mayo Clinic-Arizona State University seed grant program awards funding
The 2017 Mayo Clinic-Arizona State University seed grant program has selected eight research teams for funding. The projects draw on the strengths of each of the institutions and feature a lead investigator from each.
The program has funded promising new research collaborations for 13 years.
The lead investigators and projects are:
- Nandita Khera, M.D. (HEMO ’11), Hematology/Oncology, Mayo Clinic; Wonsun Kim, Ph.D., ASU; “Coping with hematopoietic stem cell transplantation and psychosocial distress: development of digital storytelling intervention for caregivers”
- Farouk Mookadam, M.B., B.Ch. (CV ’98), Cardiovascular Diseases, Mayo Clinic; Glenn Gaesser, Ph.D., ASU; “Diet, vascular health and the gut microbiome in heart failure”
- Michael Barrett, Ph.D. (HSR ’14), Health Sciences Research, Mayo Clinic; Melissa Wilson Sayres, Ph.D., ASU; “Evolution of X-inactivation in breast cancers”
- Thai Ho, M.D., Ph.D. (HEMO ’12), Hematology/Oncology, Mayo Clinic; Douglas Lake, Ph.D., ASU; “Functional characterization of vascular endothelial growth factor receptor inhibitors on T cell function”
- Bryan Ganter, M.D. (PMR ’97), Physical Medicine and Rehabilitation, Mayo Clinic; Meghan Vidt, Ph.D., ASU; “Rotator cuff tears in older adults: assessment of upper limb function and the underlying movement strategies”
- Catherine Chong, Ph.D. (N ’14), Neurology, Mayo Clinic; Jing Li, Ph.D., ASU; “Sex-specific profiles of white matter repair following concussion: a longitudinal diffusion tensor imaging study in young athletes”
- Yan Asmann, Ph.D. (GI ’00, LABM ’01), Health Sciences Research, Mayo Clinic; Li Liu, M.D., ASU; “Subclonal composition: prognostic role in acute myeloid leukemia patients with minimal residual disease”